167

Cardiology & Vascular surgery
Focuses on heart and vascular health.
Sub Categories on Cardiology & Vascular surgery
Latest Articles
Guidelines combine peripheral arterial, aortic diseases, emphasizing whole arterial system interconnectivity

Guidelines combine peripheral arterial, aortic diseases, emphasizing whole arterial system interconnectivity

byEuropean Society of CardiologyCredit: CC0 Public DomainThe 2024 European Society of Cardiology (ESC) Guidelines for the management of peripheral arterial and aortic diseases (PAAD) evaluate th

Guidelines combine peripheral arterial, aortic diseases, emphasizing whole arterial system interconnectivity

byEuropean Society of CardiologyCredit: CC0 Public DomainThe 2024 European Society of Cardiology (ESC) Guidelines for the management of peripheral arterial and aortic diseases (PAAD) evaluate th
Study: Targeting deubiquitinase OTUB1 protects vascular smooth muscle cells in atherosclerosis by modulating PDGFRβ

Study: Targeting deubiquitinase OTUB1 protects vascular smooth muscle cells in atherosclerosis by modulating PDGFRβ

by Higher Education PressCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-024-1056-8A recent study investigates the role of the deubiquitinase OTUB1 in vascular smooth muscle cells

Study: Targeting deubiquitinase OTUB1 protects vascular smooth muscle cells in atherosclerosis by modulating PDGFRβ

by Higher Education PressCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-024-1056-8A recent study investigates the role of the deubiquitinase OTUB1 in vascular smooth muscle cells
Study: lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression

Study: lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression

by Higher Education PressCredit: Xiang Nie, Jiahui Fan, Yanwen Wang, Rong Xie, Chen Chen, Huaping Li, Dao Wen WangResearchpresentedinFrontiers of Medicinedelves into the regula

Study: lncRNA ZNF593-AS inhibits cardiac hypertrophy and myocardial remodeling by upregulating Mfn2 expression

by Higher Education PressCredit: Xiang Nie, Jiahui Fan, Yanwen Wang, Rong Xie, Chen Chen, Huaping Li, Dao Wen WangResearchpresentedinFrontiers of Medicinedelves into the regula
Scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

Scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Summary of main findings by CNIC researchers. Clonal hematopoiesis and the expansion of blood cells carrying certain acquired

Scientists discover a new cardiovascular risk factor and identify a drug able to reduce its effects

by Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)Summary of main findings by CNIC researchers. Clonal hematopoiesis and the expansion of blood cells carrying certain acquired
Research team discovers how Copaxone protects the heart muscle and improves its function after heart attack

Research team discovers how Copaxone protects the heart muscle and improves its function after heart attack

byWeizmann Institute of ScienceCardiac sections of mice after an injury simulating a heart attack. In mice that were treated with Copaxone (bottom row), the sections reveal greater integrity of

Research team discovers how Copaxone protects the heart muscle and improves its function after heart attack

byWeizmann Institute of ScienceCardiac sections of mice after an injury simulating a heart attack. In mice that were treated with Copaxone (bottom row), the sections reveal greater integrity of
Digital consultations found to improve the rate at which heart failure patients receive optimal medication

Digital consultations found to improve the rate at which heart failure patients receive optimal medication

byAmsterdam University Medical CentersCredit: Unsplash/CC0 Public DomainPatients with heart failure, a condition affecting more than 60 million worldwide, are four times more likely to receive t

Digital consultations found to improve the rate at which heart failure patients receive optimal medication

byAmsterdam University Medical CentersCredit: Unsplash/CC0 Public DomainPatients with heart failure, a condition affecting more than 60 million worldwide, are four times more likely to receive t
Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows

Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows

byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainNew research shows that a treatment plan based on a novel combination of low doses of three anti-hypertensive drugs in a sing

Novel low-dose 3-in-1 blood pressure pill significantly outperforms standard care, study shows

byGeorge Institute for Global HealthCredit: Pixabay/CC0 Public DomainNew research shows that a treatment plan based on a novel combination of low doses of three anti-hypertensive drugs in a sing
Vutrisiran offers a new lifeline to patients with progressive heart condition

Vutrisiran offers a new lifeline to patients with progressive heart condition

byEuropean Society of CardiologyCredit: Unsplash/CC0 Public DomainVutrisiran significantly improved mortality, cardiovascular events and markers of disease progression in patients with transthyr

Vutrisiran offers a new lifeline to patients with progressive heart condition

byEuropean Society of CardiologyCredit: Unsplash/CC0 Public DomainVutrisiran significantly improved mortality, cardiovascular events and markers of disease progression in patients with transthyr
Is long-term beta-blocker therapy needed after a heart attack?

Is long-term beta-blocker therapy needed after a heart attack?

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainThe cardiovascular safety of an interrupting beta-blocker could not be shown in comparison to continuation in patients with a his

Is long-term beta-blocker therapy needed after a heart attack?

byEuropean Society of CardiologyCredit: Pixabay/CC0 Public DomainThe cardiovascular safety of an interrupting beta-blocker could not be shown in comparison to continuation in patients with a his
AI-based tongue imaging could help enable non-invasive detection of coronary artery disease

AI-based tongue imaging could help enable non-invasive detection of coronary artery disease

by Stephanie Baum , Medical XpressThe tongue diagnosis instrument and collection process. 1: lens hood, 2: LED light resource, 3: high-definition camera, 4: chin support plate. Note. Use fixed standar

AI-based tongue imaging could help enable non-invasive detection of coronary artery disease

by Stephanie Baum , Medical XpressThe tongue diagnosis instrument and collection process. 1: lens hood, 2: LED light resource, 3: high-definition camera, 4: chin support plate. Note. Use fixed standar
Urban noise pollution may impact cardiovascular risk prediction and prognosis after a heart attack

Urban noise pollution may impact cardiovascular risk prediction and prognosis after a heart attack

byEuropean Society of CardiologyCredit: Unsplash/CC0 Public DomainResearch from two studies in different European cities highlights that urban noise pollution has a significant negative impact o

Urban noise pollution may impact cardiovascular risk prediction and prognosis after a heart attack

byEuropean Society of CardiologyCredit: Unsplash/CC0 Public DomainResearch from two studies in different European cities highlights that urban noise pollution has a significant negative impact o
Semaglutide reduces risk for major adverse cardiovascular events in patients with obesity and heart failure

Semaglutide reduces risk for major adverse cardiovascular events in patients with obesity and heart failure

by Elana GotkineSemaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and hear

Semaglutide reduces risk for major adverse cardiovascular events in patients with obesity and heart failure

by Elana GotkineSemaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or obesity and hear